Stock Evaluator: SI-BONE, Inc. (SIBN)

SI-BONE, Inc. SIBN

$17.76 -0.23 -1.28%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 366,413
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Commentary & Analysis


Financial Summary

Share Statistics SIBN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $787.6 $337.2 42%
Shares Out (Mil) 44.0 41.9 45%
Institutional Ownership 96.8% 77.8% 71%
Float (Mil) 42.8 34.7 44%
Beta 0.67 0.85 39%
Avg Daily Volume (000s) 469 278 58%
Price Change
(52-week)
(0.2%) 58.7% 45%
Growth SIBN Industry
Median
Percentile
(All Stocks)
Sales (5yr) 22.3% 11.8% 84%
Net Income (5yr) 15.4% (5.8%) 64%
EPS (5yr) 21.8% 11.4% 71
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (35.1%) (16.3%) 15%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 8 8 8
Current EPS ($0.150) ($0.424) ($0.344)
Month Ago EPS ($0.154) ($0.429) ($0.353)
# Rev Up 0 0 2
# Rev Down 0 1 1
Three Months Ago EPS ($0.160) ($0.500) ($0.381)
Year/Year Chg 51.5% (3.6%) (55.5%)
Financials SIBN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $206 $152 32%
Net Income (TTM) (Mil) ($17) ($10) 25%
EPS (TTM) ($0.385) ($0.500) 30%
Operating Cash Flow (TTM) (Mil) $2 ($2) 34%
Net Cash Flow (TTM) (Mil) ($8) $1 32%
Long-Term Debt (Q1) (Mil) $42 $22 38%
Enterprise Value (Q1) (Mil) $549 $304 35%
Valuation SIBN Industry
Median
Percentile
(All Stocks)
P/B 4.39 2.80 75%
P/E na 31.1 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios SIBN Industry
Median
Percentile
(All Stocks)
Gross Margin 79.6% 59.1% 89%
Net Margin (8.1%) (7.3%) 22%
ROA (7.1%) (13.7%) 28%
ROE (9.6%) (15.8%) 28%
Liabilities to Assets 26.3% 44.7% 18%
F-Score 6 4 69%

SI-BONE, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors